LEAD encephalopathy continues to have a case fatality rate of approximately 25% and to cause damage to the central nervous system in over one half of the survivors.1 The mechanisms by which lead is toxic to the body and causes encephalopathy are not fully understood. In the average case of pediatric lead poisoning, the total amount of lead stored in the body is in the range of 250 to 1,200 mg.2 Of this amount, 20 to 100 mg are extraskeletal, located in the blood and soft tissues.3 Furthermore, in untreated patients dying with lead encephalopathy, the concentration of lead in the brain is no less than 0.2 mg of lead per 100 gm of brain tissue.4 These facts suggest that the manifestations of lead encephalopathy are a direct result of the presence of lead in the brain tissues.
Currently, the chelating agent calcium disodium edetate (calcium
SMITH HD, KING LR, MARGOLIN EG. Treatment of Lead Encephalopathy: The Combined Use of Edetate and Hemodialysis. Am J Dis Child. 1965;109(4):322–324. doi:10.1001/archpedi.1965.02090020324011
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: